Olympus Shares Plunge After FDA Warning Letter on Six Facilities

Olympus Corp. shares tumbled the most since April 2025 after the US Food and Drug Administration issued a warning letter to the Japanese medical device maker following inspections the agency previously conducted at six facilities.

To respect copyright, we link to the source rather than republishing the full text. Read the complete article on Bloomberg.